Nvidia and Genentech make the case for AI-driven drug discovery at BIO2026
Nvidia and Genentech executives made the case for AI-driven drug discovery at BIO2026, highlighting their partnership that combines Genentech's biological data with Nvidia's computing infrastructure. Nvidia also launched…